Sukhotina N K, Speranskaia O I, Brusina L I
Zh Nevropatol Psikhiatr Im S S Korsakova. 1989;89(7):62-5.
Glial volume test (GVT) was used to assess cytotoxic antibrain antibodies in 64 schizophrenic patients and 42 patients with organic disorders of the central nervous system. The GVT changes were unspecific and reflected the general course of the disease. Serum cytotoxicity increased with increasing psychopathological signs and reduced to normal or subnormal values with their alleviation. The results of the treatment were dependent on the baseline GVT levels. The test can be used as an objective prognostic criterion for the course of the disease and treatment efficiency.
胶质体积试验（GVT）用于评估64例精神分裂症患者和42例中枢神经系统器质性疾病患者体内的细胞毒性抗脑抗体。GVT变化是非特异性的，反映了疾病的总体进程。血清细胞毒性随着精神病理症状的加重而增加，随着症状的缓解而降至正常或低于正常水平。治疗结果取决于GVT的基线水平。该试验可作为疾病进程和治疗效果的客观预后标准。
